463 related articles for article (PubMed ID: 19731321)
1. 2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte Society.
Weitzman S; Braier J; Donadieu J; Egeler RM; Grois N; Ladisch S; Pötschger U; Webb D; Whitlock J; Arceci RJ
Pediatr Blood Cancer; 2009 Dec; 53(7):1271-6. PubMed ID: 19731321
[TBL] [Abstract][Full Text] [Related]
2. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of continuous infusion 2-CDA (cladribine) in pediatric patients with Langerhans cell histiocytosis.
Stine KC; Saylors RL; Saccente S; McClain KL; Becton DL
Pediatr Blood Cancer; 2004 Jul; 43(1):81-4. PubMed ID: 15170896
[TBL] [Abstract][Full Text] [Related]
4. Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine.
Dhall G; Finlay JL; Dunkel IJ; Ettinger LJ; Kellie SJ; Allen JC; Egeler RM; Arceci RJ
Pediatr Blood Cancer; 2008 Jan; 50(1):72-9. PubMed ID: 17455311
[TBL] [Abstract][Full Text] [Related]
5. Outcome of pediatric patients with Langerhans cell histiocytosis treated with 2 chlorodeoxyadenosine: a nationwide survey in Japan.
Imamura T; Sato T; Shiota Y; Kanegane H; Kudo K; Nakagawa S; Nakadate H; Tauchi H; Kamizono J; Morimoto A
Int J Hematol; 2010 May; 91(4):646-51. PubMed ID: 20361277
[TBL] [Abstract][Full Text] [Related]
6. Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study.
Morimoto A; Ikushima S; Kinugawa N; Ishii E; Kohdera U; Sako M; Fujimoto J; Bessho F; Horibe K; Tsunematsu Y; Imashuku S;
Cancer; 2006 Aug; 107(3):613-9. PubMed ID: 16804933
[TBL] [Abstract][Full Text] [Related]
7. Nationwide survey of single-system single site Langerhans cell histiocytosis in Japan.
Morimoto A; Ishida Y; Suzuki N; Ohga S; Shioda Y; Okimoto Y; Kudo K; Ishii E;
Pediatr Blood Cancer; 2010 Jan; 54(1):98-102. PubMed ID: 19728332
[TBL] [Abstract][Full Text] [Related]
8. Activity and toxicity of 2-CDA in Langerhans cell histiocytosis: a single institutional experience.
Biswas G; Khadwal A; Arora B; Bhagwat R; Banavali SD; Nair CN; Pai SK; Kurkure PA; Parikh PM
Indian J Cancer; 2007; 44(4):137-41. PubMed ID: 18322355
[TBL] [Abstract][Full Text] [Related]
9. A phase II trial using thalidomide for Langerhans cell histiocytosis.
McClain KL; Kozinetz CA
Pediatr Blood Cancer; 2007 Jan; 48(1):44-9. PubMed ID: 16333818
[TBL] [Abstract][Full Text] [Related]
10. Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator.
Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H;
Med Pediatr Oncol; 2002 Dec; 39(6):581-5. PubMed ID: 12376981
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary Langerhans cell histiocytosis: a variable disease in childhood.
Odame I; Li P; Lau L; Doda W; Noseworthy M; Babyn P; Weitzman S
Pediatr Blood Cancer; 2006 Dec; 47(7):889-93. PubMed ID: 16276522
[TBL] [Abstract][Full Text] [Related]
12. Craniospinal Langerhans cell histiocytosis in children: 30 years' experience at a single institution.
Davidson L; McComb JG; Bowen I; Krieger MD
J Neurosurg Pediatr; 2008 Mar; 1(3):187-95. PubMed ID: 18352762
[TBL] [Abstract][Full Text] [Related]
13. Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction.
Bernard F; Thomas C; Bertrand Y; Munzer M; Landman Parker J; Ouache M; Colin VM; Perel Y; Chastagner P; Vermylen C; Donadieu J
Eur J Cancer; 2005 Nov; 41(17):2682-9. PubMed ID: 16291085
[TBL] [Abstract][Full Text] [Related]
14. [Langerhans cell histiocytosis in adult patients--a disease with many faces. Experience of a centre and an overview of the disease symptoms].
Adam Z; Pour L; Krejcí M; Neubauer J; Vanícek J; Vasků V; Hájek R
Vnitr Lek; 2008 Nov; 54(11):1063-80. PubMed ID: 19069680
[TBL] [Abstract][Full Text] [Related]
15. Langerhans' cell histiocytosis in adults: a clinical and therapeutic analysis of 11 patients from a single institution.
Giona F; Caruso R; Testi AM; Moleti ML; Malagnino F; Martelli M; Ruco L; Giannetti GP; Annibali S; Mandelli F
Cancer; 1997 Nov; 80(9):1786-91. PubMed ID: 9351548
[TBL] [Abstract][Full Text] [Related]
16. [Langerhans cell histiocytosis in childhood--results of the DAL-HX 83 study].
Gadner H; Heitger A; Ritter J; Göbel U; Janka GE; Kühl J; Bode U; Spaar HJ
Klin Padiatr; 1987; 199(3):173-82. PubMed ID: 3498085
[TBL] [Abstract][Full Text] [Related]
17. Hungarian experience with Langerhans cell histiocytosis in childhood.
Müller J; Garami M; Hauser P; Schuler D; Csóka M; Kovács G; Rényi I; Kovács G; Marosi A; Galántai I; Békési A; Kajtár P; Kiss CS; Nagy K; Bartyik K; Masáth P; Kriván G;
Pediatr Hematol Oncol; 2006 Mar; 23(2):135-42. PubMed ID: 16651242
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous Langerhans cell histiocytosis in children under one year.
Lau L; Krafchik B; Trebo MM; Weitzman S
Pediatr Blood Cancer; 2006 Jan; 46(1):66-71. PubMed ID: 16261594
[TBL] [Abstract][Full Text] [Related]
19. Langerhans cell histiocytosis in neonates.
Minkov M; Prosch H; Steiner M; Grois N; Pötschger U; Kaatsch P; Janka-Schaub G; Gadner H
Pediatr Blood Cancer; 2005 Nov; 45(6):802-7. PubMed ID: 15770639
[TBL] [Abstract][Full Text] [Related]
20. Improved outcome of refractory Langerhans cell histiocytosis in children with hematopoietic stem cell transplantation in Japan.
Kudo K; Ohga S; Morimoto A; Ishida Y; Suzuki N; Hasegawa D; Nagatoshi Y; Kato S; Ishii E
Bone Marrow Transplant; 2010 May; 45(5):901-6. PubMed ID: 19767778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
